Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 608 participants.
Also called NCT04817215
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 608 participants
- Sponsor
- Registry
-
NCT04817215
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04817215. Randomized; double masking; primary purpose treatment. Start 2021-10 (anticipated); primary completion 2022-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- ORMD-0801
- Lead sponsor
- King Hamad University Hospital, Bahrain
- Collaborator
- Royal College of Surgeons in Ireland - Medical University of Bahrain
- Collaborator
- Oramed, Ltd.
Record details
- Record id
cardio:ct-nct04817215- Content hash
66f9869274edc22a2af03dc346835be6401d7859cf27f2685364c88a10d7f1ce